In this paper, chaetocin can bind to TKT, preventing its expression and enzyme activity, disrupting intracellular metabolism and oxidation-reduction balance, and subsequently controlling the PI3K/Akt signaling pathway to inhibit NSCLC growth and trigger apoptosis (Figure 7). The gene discussed is TKT; the disease is non-small cell lung carcinoma.